The challenge facing MSME pharma researchers in India
India has taken encouraging steps to promote research, but without regulatory protection for clinical trial data, the full impact of these initiatives may remain limited. Policy support for innovation must be matched by a framework that protects the value of the evidence innovators generate
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.